Finance

Lists
TMAN:BKK
T Man Pharmaceutical PCL
10,30 ฿
-0,96%
(-0,100) 1D
15 қаз., 16:40:00 GMT+7  ·   THB
All symbols
SymbolPriceChange% Change
Generating top insights for TMAN...
Open
10,40 ฿
High
10,50 ฿
Low
10,30 ฿
Mkt. cap
4,12 млрд
Avg. vol.
332,63 м.
Volume
221,82 м.
Dividend
5,44%
Quarterly dividend
0,14 ฿
Ex-dividend date
2026 ж. 26 там.
P/E ratio
8,16
52-wk high
13,60 ฿
52-wk low
9,95 ฿
EPS
1,26 ฿
Shares outstanding
400,00 млн
No. of employees
1 мың
Open
10,40 ฿
High
10,50 ฿
Low
10,30 ฿
Mkt. cap
4,12 млрд
Avg. vol.
332,63 м.
Volume
221,82 м.
Dividend
5,44%
Quarterly dividend
0,14 ฿
Ex-dividend date
2026 ж. 26 там.
P/E ratio
8,16
52-wk high
13,60 ฿
52-wk low
9,95 ฿
EPS
1,26 ฿
Shares outstanding
400,00 млн
No. of employees
1 мың
News stories
From web sources and news partners
About T Man Pharmaceutical PCL
CEO-
Employees1,05 мың
Founded1972
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in THB
Loading Previous Earnings...
Revenue
Net income
All values in THB
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
661,41 млн
730,15 млн
633,71 млн
594,36 млн
Cost of goods sold
377,69 млн
392,07 млн
338,37 млн
321,04 млн
Cost of revenue
377,69 млн
392,07 млн
338,37 млн
321,04 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
143,41 млн
175,59 млн
151,39 млн
155,05 млн
Operating expense
145,32 млн
177,27 млн
150,88 млн
151,66 млн
Total operating expenses
523,02 млн
569,34 млн
489,25 млн
472,70 млн
Operating income
138,40 млн
160,81 млн
144,46 млн
121,66 млн
Other non operating income
-
-
-
-
EBT including unusual items
131,64 млн
212,45 млн
139,82 млн
118,02 млн
EBT excluding unusual items
131,64 млн
155,00 млн
139,82 млн
118,02 млн
Income tax expense
19,04 млн
30,67 млн
25,18 млн
20,44 млн
Effective tax rate
14,47%
14,44%
18,01%
17,32%
Other operating expenses
-
-
-
-
Net income
112,60 млн
181,79 млн
114,63 млн
97,58 млн
Net profit margin
17,02%
24,90%
18,09%
16,42%
Earnings per share
-
0,46
0,29
-
Interest and investment income
-
-
-
-
Interest expense
-6,76 млн
-5,81 млн
-4,64 млн
-3,64 млн
Net interest expenses
-6,76 млн
-5,81 млн
-4,64 млн
-3,64 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
168,50 млн
185,85 млн
182,21 млн
158,76 млн
Gain or loss from assets sale
-
-195,74 м.
-
-
AI content may include mistakes. Learn more
Google қолданбалары